Phase 1 Clinical Trial of a Novel Proteasome Inhibitor (NPI-0052) in Patients with Lymphomas and Solid Tumors.

Autor: Kurzrock, Razelle *, Hamlin, Paul *, Younes, Anas *, Hong, David *, Gordon, Michael *, Spear, Matthew A. *, Palladino, Michael A. *, Lloyd, G. Kenneth *, Longenecker, Angie M. *, Neuteboom, Saskia T.C. *, Cropp, Gillian F. *, Hannah, Alison *, Aghajanian, Carol *
Zdroj: In Blood 16 November 2007 110(11):4504-4504
Databáze: ScienceDirect